Innoveren Scientific Inc. · OTC:IVRN
Innoveren Scientific — Medovex — Investor Presentation (July 2017)
18 slides from Innoveren Scientific's investor presentation, Jul 11, 2017
Slide 1: Medovex July 2017
at MEDOVEX July 2017
Slide 2: Safe Harbor Statement
Safe Harbor Statement
Slide 3: About Medovex
About Medovex A company dedicated to “better living through better medicine” Medovex was formed to acquire and develop a diversified portfolio of potentially ground breaking medical technology products. Criteria for selection include those products with potential for significant improvement in the q
Slide 4: Business Highlights
Business Highlights 2 Mepovex Medovex NASDAQ: MDVX + Disruptive breakthrough technology offering + Highly Significant Market Size + CE Marked + Initial Launch in progress + Orders Received + Initial Human Use Procedure Scheduled + World-class Management Team and Board of Directors
Slide 5: Facet Joint Pain - The Problem
Facet Joint Pain-The Problem 2 Mepovex Facet Joint Syndrome (FJS) Causes Pain When Facet Joints are Injured or Degenerate 3 _
Slide 6: DenerveX System - The Opportunity
DenerveX™ System-The Opportunity xm Approximately 10% of Adult Population Suffers from Chronic Back Pain’ Major Sources of Chronic Back Pain®
Slide 7: Current Treatment Options are Effective, but Temporary
vys 71 2 MEDovex Current Treatment Options are Effective, but Temporary standard RE Ablation ‘Treatment Area. Injection Standard RF Ablation Treatment Effectiveness: Treatment Effectiveness: Temporary Temporary
Slide 8: DenerveX System - The Solution
DenerveX™ System-The Solution 2 Mepovex [Tissue Removal and Ablation is the Enduring Solution + Methodology: Ablate the nerve and then remove the joint capsule so nerve doesn't reattach after regeneration. + Approximately 75% of patients reported a +50% improvement in standard pain scores and standa
Slide 9: DenerveX Combines Ablation and Scraping in one Device
) ZZ MEDOVEX | DenerveX Combines Ablation and Scraping in one | Device Portal Tube Tissue Stabilizer K-Wire Dilator Hand-Held Device =i] + se Portal Driver All Inclusive, Ready-to-Use, Single-Use Kit
Slide 10: Exclusively designed for the DenerveX system
+ Exclusively designed for the DenerveX system + Synchronization with the hand-held device for accurate therapy + Safety features: + Three Levels of Effect, based on patient BMI, designed to deliver precise therapy for each patient + 30-second timer for each use + Reset button between uses + Proprie
Slide 11: DenerveX Delivers Enduring Relief by Treating a Larger Area
Zw MeEDOvEX The DenerveX System Delivers Enduring Relief by | Treating a Larger Area and Removing the Joint Capsule Denervex System] Synovial | Standard RF | Capsule 7 Ablation Treatment} ‘Area | J
Slide 12: DenerveX System - Health Care Economics
DenerveX™ System- Health Care Economics (Over a3 year Period) <™ (DenerveX Reduces the Total Cost of Care for FJS Patients} Temporary Treatments
Slide 13: EU/Worldwide DenerveX Launch Strategy
EU/Worldwide DenerveX Launch Z Mepovex Strategy { Staged Launch Reduces Execution Risk )
Slide 14: DenerveX System - Initial Demand
DenerveX™ System- Initial Demand { Early Demand Exceeds Expectations + Initial orders received from United Kingdom, Germany, Italy, and Chile distributors + Additional product requests anticipated in other European countries, Latin America, and Asia + First cases scheduled in England and Germany in
Slide 15: DenerveX System - Dedicated Reimbursement Code
DenerveX™ System- Dedicated Reimbursement Code a MEDOVEX Strong Reimbursement will Help Drive Adoption + Dedicated DRG Code in Germany + Reimbursed at €4,000 - €6,000 + Code granted ahead of CE mark
Slide 16: Key Management & Board Members
Key Management & Board Members x Meo se | Se | soa | See | nom [| seems [ieee ores [ace Pe Pe Industry Experience of the companies Directors and Management Team MiMeax ~ENTRE MED Be mavwarion Seis a fohmonGofmen — stryker'
Slide 17: Management Bio's
Management Bio's 2 Mepovex
Slide 18: Investment Highlights
Investment Highlights 2 Mepovex Medovex NASDAQ: MDVX. + Founded by Steve Gorin (Entremed, Medicis, Medivation, (world renowned orthopedic surgeon) + Experienced and proven management team and board ofdirectors iiMedx) and Dr. James Andrews + High insider ownership (38%) * Intellectual property portf